The adjuvancy of OX40 ligand (CD252) on an HIV-1 canarypox vaccine.
Liu J, Ngai N, Stone GW, Yue FY, Ostrowski MA.
Liu J, et al. Among authors: stone gw.
Vaccine. 2009 Aug 13;27(37):5077-84. doi: 10.1016/j.vaccine.2009.06.046. Epub 2009 Jun 30.
Vaccine. 2009.
PMID: 19573639
This was in contrast to our previous work in which a CD40L-expressing construct preferentially enhanced antigen specific memory responses [Liu J, Yu Q, Stone GW, Yue FY, Ngai N, Jones RB, et al. CD40L expressed from the canarypox vector, ALVAC, can boost immunogenic …
This was in contrast to our previous work in which a CD40L-expressing construct preferentially enhanced antigen specific memory responses [L …